Join to view full profile
60 Temple StNew Haven, CT 06510
Phone+1 203-401-4300
Fax+1 203-401-4301
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 4 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kenneth Marek, MD is a board certified neurologist in New Haven, Connecticut. He is currently licensed to practice medicine in Connecticut and Maryland.
Education & Training
Johns Hopkins UniversityResidency, Neurology, 1984 - 1986- Johns Hopkins UniversityResidency, Internal Medicine, 1982 - 1984
- Johns Hopkins UniversityInternship, Internal Medicine, 1978 - 1979
Yale School of MedicineClass of 1978
Certifications & Licensure
CT State Medical License 1989 - 2027- CT State Medical License 1989 - 2025
MD State Medical License 1985 - 1989
American Board of Internal Medicine Internal Medicine
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 14 citationsStaged Screening Identifies People with Biomarkers Related to Neuronal Alpha-Synuclein Disease.Ethan G Brown, Lana M Chahine, Andrew Siderowf, Caroline Gochanour, Ryan Kurth
Annals of Neurology. 2025-04-01 - 32 citationsα-Synuclein Seed Amplification Assay Amplification Parameters and the Risk of Progression in Prodromal Parkinson Disease.David G Coughlin, Ben Shifflett, Carly M Farris, Yihua Ma, Douglas Galasko
Neurology. 2025-03-11 - 21 citationsA Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous prasinezumab in early-stage Parkinson's ...Tania Nikolcheva, Gennaro Pagano, Nathalie Pross, Tanya Simuni, Kenneth Marek
Parkinsonism & Related Disorders. 2025-03-01
Press Mentions
Michael J. Fox Foundation Discovers Breakthrough in Search for Parkinson’s BiomarkerApril 17th, 2023- Parkinson’s Test Flags Early DiseaseApril 13th, 2023
- ‘Game-Changing’ New Parkinson’s Test Paves Way for Treatments and CureApril 12th, 2023